行情

CSBR

CSBR

Champions
NASDAQ

实时行情|Nasdaq Last Sale

5.20
+0.08
+1.56%
已收盘, 16:00 11/19 EST
开盘
5.24
昨收
5.12
最高
5.50
最低
5.11
成交量
2.76万
成交额
--
52周最高
13.24
52周最低
4.976
市值
6,042.16万
市盈率(TTM)
-57.7778
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CSBR 新闻

  • 云集12月2日发布2019年第三季度财报
  • 新浪科技.40分钟前
  • 拼多多Q3净亏损超预期 盘前跌逾20%市值回落百度之后
  • 新浪财经.2小时前
  • 拼多多三季度营收低于市场预期 盘前大跌13%
  • 新浪科技.2小时前
  • 定价176港元,阿里巴巴首日盈利空间还有多大?
  • 华盛通.2小时前

更多

所属板块

生物技术和医学研究
+1.97%
制药与医学研究
+0.74%

热门股票

名称
价格
涨跌幅

CSBR 简况

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
展开

Webull提供Champions Oncology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。